Efficacy and Safety of Rivaroxaban for Postoperative Thromboprophylaxis in Patients After Bariatric Surgery
Sign Up to like & getrecommendations! Published in 2023 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2023.15241
Abstract: Key Points Question Is thromboprophylaxis with 10 mg of rivaroxaban for 7 and 28 days after bariatric surgery efficacious and safe? Findings In this randomized clinical trial, 272 patients undergoing bariatric surgery were assigned to… read more here.
Keywords: surgery; rivaroxaban postoperative; postoperative thromboprophylaxis; efficacy safety ... See more keywords
Retrospective evaluation of the efficacy and safety of rivaroxaban in patients with cancer-associated venous thromboembolism
Sign Up to like & getrecommendations! Published in 2019 at "Medicine"
DOI: 10.1097/md.0000000000016514
Abstract: Abstrct The purpose of this study was to evaluate the efficacy and safety of rivaroxaban for the treatment of cancer-associated venous thromboembolism (VTE). We performed a retrospective chart review of cancer patients with a pulmonary… read more here.
Keywords: efficacy safety; cancer associated; cancer; associated venous ... See more keywords
Efficacy and safety of rivaroxaban compared to enoxaparin in treatment of cancer‐associated venous thromboembolism
Sign Up to like & getrecommendations! Published in 2018 at "European Journal of Haematology"
DOI: 10.1111/ejh.13074
Abstract: Low molecular weight heparin (LMWH) is the guideline‐endorsed treatment for cancer‐associated venous thromboembolism (cVTE). Study objectives were to compare the efficacy and safety of rivaroxaban and enoxaparin in cVTE. read more here.
Keywords: safety rivaroxaban; efficacy safety; associated venous; venous thromboembolism ... See more keywords